Dr. rer. nat. Thomas Beder
Facts
E-Mail:
thomas.beder[at]uksh.de
Affiliations:
Clinic for Internal Medicine II, Hematology and Oncology / University Medical Center Schleswig-Holstein, Campus Kiel
Address:
Arnold-Heller-Str. 3, QFZ (Haus U18) 24105 Kiel
Curriculum Vitae
Research Experience
| Since 09/2021 | Postdoctoral Researcher at the Research Group Functional Genomics of Acute Leukemias (AG Prof. Dr. med. Claudia Baldus), University Medical Center Schleswig-Holstein, Kiel, Germany |
| 03/2018 – 03/2021 | Postdoctoral Researcher at the Research Group Systems Biology of Sepsis (AG Prof. Dr. Rainer König), Jena University Hospital, Jena, Germany |
Education/Training
| 10/2013 – 02/2020 | PhD Student (Dr. rer. nat.), Bioinformatics, Dept. of Cell Biology, Natural Product Research and Infection Biology Hans Knöll Institute, Jena, Germany |
| 10/2011 – 09/2013 | Master of Science, Molecular Life Sciences, Friedrich Schiller University Jena, Germany |
| 10/2008 – 09/2011 | Bachelor of Science, Biology, Friedrich Schiller University Jena, Germany |
Project-related publications
P1, P3, P4, P6, INF, Z
Intra-subtype heterogeneity shapes treatment response in KMT2A-rearranged ALL across all age groups
P1, P3, P4, Z
Venetoclax and Blinatumomab for adult patients with relapsed/refractory or MRD positive Ph-negative B-cell precursor ALL: phase I part of the GMALL-BLIVEN trial
Ann Hematol
2026
P1, P3, P4, INF
IGH::FENDRR and specific KRAS mutations define a novel B-ALL molecular subtype with poor chemotherapy response
P1, P3, P4, INF